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ng author. Tel.: +32 247
ess: marc.noppen@az.vSummary Central airway obstruction can cause severe respiratory insufficiency
leading to mechanical ventilation (MV) or artificial airway (AA) dependency.
Interventional bronchoscopic procedures have been reported to be of help in
weaning patients with malignant airway stenoses from mechanical ventilation,
whereas their use in benign disease is only anecdotal.
The objectives of this study are to evaluate early, intermediate and long-term
outcome of interventional bronchoscopy and stent placement in the treatment of
MV/AA dependency due to benign airway obstruction.
In a retrospective cohort analysis for the period 1999–2004, we evaluated 15
consecutive ICU patients with documented benign central airway obstruction, who
were referred for bronchoscopic management of their condition after multiple failed
attempts at weaning from MV or decannulation of the AA. Indications for
bronchoscopic treatment were surgery refusal, medical or surgical inoperability,
or absence of alternative treatment options.
Malacia, post-intubation stenosis and goiter were the main causes of airway
obstruction and MV/AA dependency. All patients were treated by means of rigid
bronchoscopy, dilatation procedures and stent insertion. All but one patient (93.3%)
were successfully and permanently extubated/decanulated immediately after the
bronchoscopy. Minor complications occurred in 6 patients (40%) leading to a second
intervention. All complications could be managed endoscopically and long-term
follow up was uneventful. Interventional bronchoscopy with stent insertion canElsevier Ltd. All rights reserved.
76010; fax: +32 24776840.
ub.ac.be (M. Noppen).
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M. Noppen et al.140allow successful withdrawal from MV/AA and can offer longstanding airway patency
in selected ventilator- or tracheostomy-dependant individuals with benign airway
stenoses,when surgery in not feasable or contra-indicated.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Interventional bronchoscopic procedures for treat-
ment of central airway obstruction have been well
documented and are increasingly accepted over the
last decades.1–3 Laser resection, balloon dilatation,
cryotherapy and insertion of tracheobronchial
prostheses (stents), can reestablish airway patency
and provide symptomatic relief in both malignant
and non-malignant obstructions.4
In case of respiratory failure due to malignant
central airway obstruction, palliative laser resec-
tion and stent placement have been reported to
allow level of care changes and possibly withdrawal
from mechanical ventilation (MV).5–9 However, the
clinical impact of such achievements given the
unfavorable prognosis in most cases has not been
fully established.10 On the other hand, given the
more favorable prospects, one would suspects that
these techniques would be of greater benefit in a
subgroup of individuals with ventilator- or artificial
airway (AA) dependency due to benign and inoper-
able airway obstruction. Currently there are only a
few anecdotal reports on such bronchoscopic
procedures with tracheal endoprosthesis (stents)
insertions leading to longstanding airway patency
and successful withdrawal from MV or AA.5,7–9,11
However, most studies were performed in a
small number of individuals with mixed benign
and malignant conditions. Furthermore, there is
scarcity of information on bronchoscopic manage-
ment of individuals who are tracheostomy depen-
dent.
Thus, this study was designed to evaluate early,
intermediate and long-term outcome of interven-
tional bronchoscopy and stent placement on in-
dividuals with ventilator- and/or tracheostomy
dependency exclusively due to benign central
airway obstruction.Materials and methods
This is a retrospective cohort analysis of a series of
15 consecutive ICU patients with established
central airway obstruction of benign origin who
despite several attempts were unable to wean from
MV or from AA dependency. They were all referredto the Interventional Endoscopy Clinic of the
University Hospital AZ-VUB for bronchoscopic treat-
ment during the study period (1999–2005). Demo-
graphic data are described as mean7SD. Other
descriptive statistics are expressed as median and
interquartile ranges.Patients
During the study period, 15 mechanically venti-
lated/ artificial airway dependent patients (7 males
and 8 females; mean age, 61.5715.4 years [7SD];
range, 15–85 years) unable to be weaned from the
ventilator or from their tracheostomy canula were
referred to our clinic, either from our local
intensive care unit (ICU) (2 patients) or from the
ICU of other institutions (13 patients). Patients’
characteristics are summarized in Table 1. All
patients had been intubated/canulated because
of acute or acute-on-chronic respiratory insuffi-
ciency due to central airway obstruction of benign
origin. They all had undergone several documented
unsuccessful weaning attempts following various
established weaning protocols (using various venti-
lation support methods) prior to referral to our
department. Stridor, hypercapnia and respiratory
muscle fatigue were the main cause for their
persistent MV/AA dependency. In all cases, the
referring physicians felt that the primary cause for
this dependency was due to either direct (e.g.
tracheomalacia) or indirect (e.g. post-obstructive
atelectasis or pneumonia) airway obstruction
(confirmed by means of flexible bronchoscopy)
and not to other underlying diseases or com-
pounded co-morbidities. Interventional broncho-
scopic management and stent insertion was
proposed after multidisciplinary counseling, and
after surgical operation was either not indicated or
was felt to be intolerable due to the individual’s co-
morbidities, or upon patient’s refusal of surgical
management.
Patient data were extracted from electronic
hospital data files. There were no missing data on
treatment or follow-up. Prior to interventional
bronchoscopy and stenting, oral informed consent
was obtained from the patients or the patients’
relatives.
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M. Noppen et al.142Bronchoscopic procedures
Bronchoscopy was always performed with a rigid
bronchoscope (Karl Storz, Tutlingen, Germany) in a
fully equipped operating theater under general
anesthesia using IV propofol, alfentanil and atra-
curium. Ventilation and oxygenation were ensured
by high-frequency jet ventilation with variable
fractional inspiratory oxygen concentrations deliv-
ered by a side port of the bronchoscope. During the
procedure all patients received hemodynamic
monitoring as well as pulse oxymetry. After the
patient was fully anesthetized the endotracheal
tube or tracheostomy canula was removed and the
rigid bronchoscope was inserted in the trachea
permitting institution of high-frequency jet venti-
lation.
Dumon studded silicone stents (Novatech; Au-
bagne, France) or self-expandable metal stents
(Ultraflex, Boston Scientific; Galway, Ireland) were
used. The choice of the stent was based mainly on
the type and length of stenosis as well as on the
nature of the causative disease. Evaluation of the
outcome for this intervention was based on
whether successful extubation and/or decannula-
tion resulting in immediate discontinuation of
mechanical ventilation and/or closure of tracheost-
omy site were possible. Furthermore, extensive
documentation of any complications during long-
term follow-up was made and included in our final
analysis.
Discharge and follow up
All patients were discharged within a week after
the intervention and continued to be under close
surveillance with regular examination every 3
months for the first year or when a complication
occurred. After clinical stability was ensured,
follow up continued with clinical and endoscopical
examination once or twice a year. Median follow up
was 19.6 months (range 4–68 months).Results
Fourteen out of the 15 patients (93.3%) were
extubated in the operating room immediately after
the intervention. They were followed for 1–3 days
in the ICU and monitored for oxygen saturation,
cardiac and hemodynamic parameters. All of these
14 patients were able to regain spontaneous
breathing after intervention and none had to be
re-intubated during follow up. One patient (nr 11)
had to be reintubated within a few hours after the
ARTICLE IN PRESS
Stenting allows weaning 143procedure, and remained intubated and ventilated
until death 2 months later.
Median average duration of mechanical ventila-
tion prior to referral for interventional manage-
ment was 30 days (range 7–105). Tracheomalacia,
postintubation stenosis, intrathoracic (substernal)
goiter and post-pneumonectomy syndrome with
bronchomalacia and obstruction of left main
bronchus were the main etiologies of airway
obstruction. Patients 6 and 8 had been stented
prior to the development of respiratory insuffi-
ciency and in their case tracheal stenosis (due to
granulation tissue on the stent and weakening of
the metallic mesh, respectively) was related to
their previous stent treatment. Poor physicalTable 2 Interventions and outcomes (Positive ¼ allowin
Stent used Complications
1 1cov Ultraflex
18 60mm
Granuloma formation treated
cryo therapy after 10 months
2 1cov Ultraflex
18 60mm
Granuloma formation. 2 Dum
over both previous stent’s edg
3 1cov Ultraflex
16 40mm
Fracture of stent after 6 mon
by a new one. 2 months late
formation treated with cryoth
of a 2nd stent
4 1cov Ultraflex
16 40mm
No complications
5 Dumon stent
16 40mm
No complications
6 1cov Ultraflex
18 40mm
(Trachea) and 1
Ultraflex
14 40mm
(LMB)
Granuloma formation proxim
laser and cryotherapy after 5
7 1cov Ultraflex
18 60mm
No complications
8 1cov Ultraflex
18 60mm
No complications
9 1cov Ultraflex
16 40mm
No complications
10 Dumon stent
16 60mm
Reintervention 4 weeks later
plugging of the stent
11 1cov Ultraflex
16 40mm
No complications
12 Dumon stent
15 70mm
No complications
13 Dumon stent
14 60mm
Migration and stent repositio
14 Dumon stent
16 60mm
No complications
15 1cov Ultraflex
18 60mm
No complications
LMB, left main bronchus.status, severe comorbidities and/or extensive dis-
ease did not allow for a safe surgical approach in 14
out of 15 patients. In six cases (patients 3,6,8–11)
the tracheobronchial stenosis caused recurrent
post-obstructive atelectasis and/or pneumonia
complicated by sepsis.
Obstruction was localized in upper or mid
trachea in 12 out of 15 cases and at the left main
bronchus in three cases. Twenty stents (both
silicone (7) and metal (13)) were placed in 15
patients. Interventions, complications and out-
comes are outlined in Table 2.
Complications occurred in 6 (40%) of the treated
patients leading to a second session of therapeutic
bronchoscopy after some months. Patients 1 and 2g immediate detubation/decanulation).
Final outcome /follow up since
1st intervention (months)
with laser and Positive/54
on stents placed
es after 12 months
Positive/48
ths, being replaced
r granuloma
erapy and addition
Positive/44
Positive/42
Positive/40
ally treated with
months
Positive/34
Positive/30
Positive/24
Positive/18
because of mucus Positive/9
Negative/death after 2 months
Positive/3
ning at 6 weeks Positive/3
Positive/2
Positive/1
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M. Noppen et al.144developed granulation tissue over the stent’s edges
after 10 and 12 months, respectively. One patient
received laser resection and cryotherapy for his
granulomas while additional deployment of two
more stents was necessary in the second. Both had
an uneventful follow up. The self-expandable
metal stent in patient 3 (post-pneumonectomy
syndrome) fractured 6 months after deployment
and had to be replaced by a new stent. In the
following 2 months granulation tissue developed at
the new stent’s extremities and the patient had to
be treated again with cryotherapy and the addition
of one more stent. Almost 2 years since the last
intervention this patient remains asymptomatic
and able to continue her usual activities. Patient
6, after having been treated with covered Ultraflex
stents over his ancient Gianturco stents, developed
granulomas 5 months after intervention and had a
laser resection and cryotherapy performed without
further complications during follow up. Patient 10
was readmitted 4 weeks after treatment because of
acute dyspnea due to a mucus plug blocking the
stent; after bronchoscopic cleaning and emphasiz-
ing aerosol treatment, no recurrences were ob-
served. Patient 13 was readmitted 6 weeks after
treatment with stridor and dyspnea, due to a distal
migration of the Dumon stent. At re-intervention,
the stent was repositioned and no migration has
occurred since. This occurrence of stent-related
complications confirms that stenting should be
considered a therapeutic alternative only when
definitive surgery is not feasible or contra-
indicated.
In one patient (nr 11) permanent extubation
after stenting failed within a few hours, and
mechanical ventilation had to be restored. She
suffered from severe COPD, severe congestive
heart failure and pulmonary hypertension, with
vascular compression of the left mained bronchus
leading to respiratory insufficiency and postob-
structive infections. Despite stenting of the left
main bronchus, weaning from mechanical ventila-
tion was impossible, and she remained ventilator
dependent, due to the severe underlying comor-
bidity. She died 8 weeks later.Discussion
This is the first study to report on the early,
intermediate and long-term outcome of interven-
tional bronchoscopic management of patients with
ventilator- or tracheostomy dependency exclu-
sively due to benign airway obstruction. 93.3% of
patients were successfully treated with placementof silicone or metal stents through rigid broncho-
scopy, allowing for immediate extubation, with-
drawal of mechanical ventilation or tracheostomy
canula, and permanent airway patency.
There have been only few reports on the
application of interventional bronchoscopy and
airway stenting in ventilator- or artificial airway
dependency due to central airway stenosis. Most
reported series concern palliative treatment of
malignant obstructions inevitably addressing ethi-
cal questions on the real clinical impact and the
cost effectiveness of such an approach.6,10 Reports
of ventilator dependency due to non-malignant
airway strictures are scarce in the literature, and
are presented in mixed series together with
interventions on malignant tracheobronchial stric-
tures: Zannini et al.7 report on 5 patients with non-
malignant central airway lesions and 1 with
malignant obstruction successfully treated with
tracheal or bronchial placement of older genera-
tion Gianturco stents. Colt and Harell5 using various
bronchoscopic techniques were able to extubate 7
out of 8 ventilator-dependent patients with non-
malignant obstruction and 2 out of 11 patients with
malignant obstruction, while Shaffer and Allen8
reported 2 patients with non-malignant and 6
patients with malignant obstruction successfully
extubated after fiberscopic stenting with various
auto-expandable stents. Finally, Lippman et al.9
recently reported on three cases (one non-malig-
nant and two malignant) treated with Wallstents by
means of flexible bronchoscopy under fluoroscopic
guidance. We found no literature data on the
possible role of stenting in case of impossible
removal of tracheostomy canula’s.
The main etiologies of non-malignant central
airway obstruction found in our series were in
accordance with those reported in the litera-
ture1,2,7 and included post intubation tracheal
stenosis with or without associated tracheomala-
cia, chronic extrinsic tracheal compression (i.e.
from a mediastinal goiter or a non-malignant
tumor), post pneumonectomy syndrome, tracheo-
malacia associated with chronic obstructive lung
disease (COPD) and relapsing polychondritis. All
these airway diseases, if inoperable, may be
indications for the placement of tracheobronchial
stents. When the malacic portion of the airway is
not predominant or when the extrinsic force is too
high for a wire stent, silicon Dumon stent offering
greater radial force can be used with the additional
advantages of being less expensive than its metallic
counterparts and its effortless extractability. This
type of stent was used in five patients. In all other
patients in this study, covered metallic (nitinol)
self-expandable stents were deployed. The major
ARTICLE IN PRESS
Stenting allows weaning 145advantages of this type of stent include smaller
migration rate, greater cross-sectional airway
diameter (due to thinner wall construction),
‘‘shape memory’’ elastic characteristics, better
conforming to irregular airways and epithelializa-
tion within the stent, allowing for maintenance of
mucociliary clearance.
Respiratory insufficiency in patients with inoper-
able benign central airway obstruction can lead to
dependency on mechanical ventilation or tra-
cheostomy, poor overall prognosis and high costs
of hospital and/or ambulatory care. Obviously, the
decision for stent placement should be taken only
when the respiratory failure is a result of an
inoperable central airway stenosis and when this
stenosis is amenable to bronchoscopic intervention.
It is important to emphasize that some patients
with persistent MV or AA dependency may have an
unappreciated airway stenosis. It therefore be-
hooves the responsible physician to further evalu-
ate these patients with computed tomography (CT
scan) or fiberoptic bronchoscopy, inspecting the
entire length of the airway to rule out such
obstructions as the cause for the patients’ inability
to be weaned.
Three out of the twelve Ultraflex stents that
were deployed (25%) resulted in granulation tissue
formation necessitating a second interventional
treatment. None of these complications however
were acute or life threatening and after the second
treatment all patients had an uneventful follow up
of many months. The usual rate of granuloma
formation in non-malignant cases is reported to be
between 6% and 20% for Dumon stents12 while still
undefined (due to lack of large series) for the
Ultraflex stents.13 According to our unpublished
experience regarding more than 100 non-malignant
cases where Ultraflex stents were deployed, the
rate of granuloma formation seems comparable in
these patients. Stent fracture occurred in the case
of post-pneumonectomy syndrome possibly because
of the exceptionally high extrinsic force applied to
the bronchial wall. In this case one could advocate
for the use of a silicone stent if this was not so
disadvantageous regarding its lumen/wall thickness
ratio in a medium-sized left main bronchus.
Although systematic use of metallic stents in benign
disease is not advocated,their use can be imposed
by the characteristics of the stenotic lesion.
Furthermore, recent reports14,15 have shown that
these stents can be removed safely when necessary.
Nevertheless, stent-related complications occur
frequently during long-term follow-up ,confirming
that stenting should be considered only whendefinitive surgery is not feasible or contra-
indicated.
We conclude that rigid bronchoscopic stent
insertion can safely and effectively allow with-
drawal from mechanical ventilation and from
tracheostomy, and provide early, intermediate
and long-term airway patency in selected patients
with benign airway obstruction causing ventilator-
or tracheostomy dependency. Although minor com-
plications may occur, they are treatable by simple
endoscopic therapy. Stent placement should there-
fore be considered as a potential therapeutic
maneuver when definitive surgery is not feasible
or contra-indicated.
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